124 related articles for article (PubMed ID: 36156294)
1. Surface modified genistein phytosome for breast cancer treatment: In-vitro appraisal, pharmacokinetics, and in-vivo antitumor efficacy.
Komeil IA; Abdallah OY; El-Refaie WM
Eur J Pharm Sci; 2022 Dec; 179():106297. PubMed ID: 36156294
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamic evaluation of hyaluronic acid-modified imatinib-loaded PEGylated liposomes in CD44-positive Gist882 tumor-bearing mice.
Huang J; Chen J
J Liposome Res; 2024 Mar; 34(1):97-112. PubMed ID: 37401372
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of genistein for pancreatic cancer treatment using hyaluronic-coated cubosomes bioactivated with frankincense oil.
Sallam NG; Boraie NA; Sheta E; El-Habashy SE
Int J Pharm; 2024 Jan; 649():123637. PubMed ID: 38008234
[TBL] [Abstract][Full Text] [Related]
4. Development and Evaluation of a Novel Hyaluronic Acid and Chitosan-modified Phytosome for Co-delivery of Oxymatrine and Glycyrrhizin for Combination Therapy.
Chen X; Yu S; Wang P; Zhao X; Sang G
Recent Pat Anticancer Drug Discov; 2024; 19(2):154-164. PubMed ID: 38214355
[TBL] [Abstract][Full Text] [Related]
5. Folate receptor-targeted PLGA-PEG nanoparticles for enhancing the activity of genistein in ovarian cancer.
Patra A; Satpathy S; Naik PK; Kazi M; Hussain MD
Artif Cells Nanomed Biotechnol; 2022 Dec; 50(1):228-239. PubMed ID: 36330543
[TBL] [Abstract][Full Text] [Related]
6. Phytosome-hyaluronic acid systems for ocular delivery of L-carnosine.
Abdelkader H; Longman MR; Alany RG; Pierscionek B
Int J Nanomedicine; 2016; 11():2815-27. PubMed ID: 27366062
[TBL] [Abstract][Full Text] [Related]
7. Oral genistein-loaded phytosomes with enhanced hepatic uptake, residence and improved therapeutic efficacy against hepatocellular carcinoma.
Komeil IA; El-Refaie WM; Gowayed MA; El-Ganainy SO; El Achy SN; Huttunen KM; Abdallah OY
Int J Pharm; 2021 May; 601():120564. PubMed ID: 33812970
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes.
Qhattal HS; Hye T; Alali A; Liu X
ACS Nano; 2014 Jun; 8(6):5423-40. PubMed ID: 24806526
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and pharmacokinetics study of a novel genistein-loaded mixed micelles system.
Shen H; He D; Wang S; Ding P; Wang J; Ju J
Drug Dev Ind Pharm; 2018 Sep; 44(9):1536-1542. PubMed ID: 29848136
[TBL] [Abstract][Full Text] [Related]
10. In vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor.
Uckun FM; Narla RK; Zeren T; Yanishevski Y; Myers DE; Waurzyniak B; Ek O; Schneider E; Messinger Y; Chelstrom LM; Gunther R; Evans W
Clin Cancer Res; 1998 May; 4(5):1125-34. PubMed ID: 9607569
[TBL] [Abstract][Full Text] [Related]
11. Solutol
Ding P; Chen Y; Cao G; Shen H; Ju J; Li W
Drug Des Devel Ther; 2019; 13():1947-1956. PubMed ID: 31239645
[No Abstract] [Full Text] [Related]
12. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
[TBL] [Abstract][Full Text] [Related]
13. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
[TBL] [Abstract][Full Text] [Related]
14. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
[TBL] [Abstract][Full Text] [Related]
15. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting.
Tiantian Y; Wenji Z; Mingshuang S; Rui Y; Shuangshuang S; Yuling M; Jianhua Y; Xinggang Y; Shujun W; Weisan P
Int J Pharm; 2014 Aug; 471(1-2):245-57. PubMed ID: 24858386
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of folate-targeted and PEGylated phytosomes loaded with a mitomycin C-soybean phosphatidyhlcholine complex.
Li Y; Wu H; Jia M; Cui F; Lin J; Yang X; Wang Y; Dai L; Hou Z
Mol Pharm; 2014 Sep; 11(9):3017-26. PubMed ID: 25054963
[TBL] [Abstract][Full Text] [Related]
17. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
[TBL] [Abstract][Full Text] [Related]
18. Four-arm PEG cross-linked hyaluronic acid hydrogels containing PEGylated apoptotic TRAIL protein for treating pancreatic cancer.
Byeon HJ; Choi SH; Choi JS; Kim I; Shin BS; Lee ES; Park ES; Lee KC; Youn YS
Acta Biomater; 2014 Jan; 10(1):142-50. PubMed ID: 24021228
[TBL] [Abstract][Full Text] [Related]
19. Phytosterol-loaded CD44 receptor-targeted PEGylated nano-hybrid phyto-liposomes for synergistic chemotherapy.
Gautam M; Thapa RK; Gupta B; Soe ZC; Ou W; Poudel K; Jin SG; Choi HG; Yong CS; Kim JO
Expert Opin Drug Deliv; 2020 Mar; 17(3):423-434. PubMed ID: 32028805
[No Abstract] [Full Text] [Related]
20. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
